Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants
Clinical trial NCT05584202 · TERMINATED
Trial details
- NCT number
- NCT05584202
- Sponsor
- ModernaTX, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2024-11-15
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.